Selected article for: "Coronavirus platform topic and inclusion decide"
Author: Rocio Bravo Jeria; Maria X Rojas Reyes; Juan V Franco; Maria P Acuna; Luz A Torres Lopez; Gabriel rada Rada
Title: Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol
  • Document date: 2020_4_8
    • ID: fckn8ld4_64
    Snippet: An artificial intelligence algorithm deployed in the Coronavirus/COVID-19 topic of the L·OVE platform ( https://app.iloveevidence.com/loves/5e6fdb9669c00e4ac072701d ) will provide instant notification of articles with a high likelihood to be eligible. The authors will review these and will decide upon inclusion, and will update the living web version of the review accordingly. We will consider resubmission to a journal if there is a change in th.....
    Document: An artificial intelligence algorithm deployed in the Coronavirus/COVID-19 topic of the L·OVE platform ( https://app.iloveevidence.com/loves/5e6fdb9669c00e4ac072701d ) will provide instant notification of articles with a high likelihood to be eligible. The authors will review these and will decide upon inclusion, and will update the living web version of the review accordingly. We will consider resubmission to a journal if there is a change in the direction of the effect on the critical outcomes or a substantial modification to the certainty of the evidence. This review is part of a larger project set up to produce multiple parallel systematic reviews relevant to COVID-19 [19] . 9 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and critical outcome: 1
    • cc NC ND International license and evidence certainty: 1, 2, 3, 4
    • cc NC ND International license and evidence certainty substantial modification: 1
    • cc NC ND International license and high likelihood: 1, 2, 3
    • cc NC ND International license and inclusion decide: 1
    • cc NC ND International license and instant notification: 1
    • cc NC ND International license and intelligence algorithm: 1
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and journal resubmission consider: 1
    • cc NC ND International license and platform topic: 1
    • cc NC ND International license and resubmission consider: 1
    • cc NC ND International license and substantial modification: 1
    • cc NC ND International license and web version: 1
    • Coronavirus platform topic and International license: 1
    • Coronavirus platform topic and journal resubmission consider: 1, 2
    • Coronavirus platform topic and platform topic: 1, 2
    • Coronavirus platform topic and resubmission consider: 1, 2
    • Coronavirus platform topic and substantial modification: 1, 2
    • Coronavirus platform topic and web version: 1, 2